Ben and Catherine Ivy Foundation
EIN 273322123 Private Foundation
Possibly inactive.
Last 990-PF filing on record is from 2023
(3 years ago). Verify before investing time in an application.
Total Given 2021–2023
$47.7M
83 grants · $15.9M avg/year
based on 3 yrs of IRS 990-PF records on file
$10M+/yr
major funder
capacity
$299K
typical big bets · $125K–$300K
grant size
60%
deep partner · 24/40 multi-year
repeat
$333.2M
Assets (2023)
40
Distinct Recipients
About
INVESTMENT CONSULTING
Focus Areas
Application Information
Accepts Unsolicited Proposals
No. Preselected Only
Contact Person
httpwwwivyfoundationorg
Phone
(480) 659-9621
Financial Trends
Giving Over Time
Total Assets Over Time
View financial data as table
| Year | Total Giving | Total Assets | Revenue | Grants |
|---|---|---|---|---|
| 2021 | $16.4M | $376.9M | $22.4M | 25 |
| 2022 | $16.3M | $301.6M | $10.8M | 30 |
| 2023 | $15.0M | $333.2M | $13.5M | 28 |
Grant Size Distribution
Based on 83 grants on record
Minimum
$150
25th Pctl
$125K
Median
$299K
Average
$575K
75th Pctl
$300K
Maximum
$6.0M
Geographic Distribution
Texas Counties Served
7.2% of US grants
· Rank #4 of 16 states
$1.5M across
6 grants
2 of 254 counties
Top 2 counties
- 1 Harris
- 2 Dallas
Officers & Directors
Grants Awarded (83 total)
| Purpose | ||||
|---|---|---|---|---|
| St Joseph's Foundation | Phoenix, AZ | $5,970,000 | IVY BRAIN TUMOR CENTER AT BARROW NEUROLOGICAL INSTITUTE CAPITAL EXPENDITURES. | 2023 |
| Neurotrials Llc | Phoenix, AZ | $5,470,000 | PREPAYMENT OF 2023 CEREBROSPINAL FLUID ANALYSIS. | 2022 |
| Neurotrials Llc | Phoenix, AZ | $5,152,500 | IVY BRAIN TUMOR CENTER. PAYMENTS 4 & 5. | 2021 |
| Neuro Trials Llc | Phoenix, AZ | $5,000,000 | IVY BRAIN TUMOR CENTER BUILDING EXPANSION. PAYMENT 2. | 2021 |
| Neuro Trials Llc | Phoenix, AZ | $5,000,000 | IVY BRAIN TUMOR CENTER BUILDING EXPANSION SPECIAL GRANT AMENDMENT. | 2022 |
| Neuro Trials Llc | Phoenix, AZ | $3,800,935 | MULTIPLE AWARDS:1) DEVELOPMENT OF TRIPLE-DRUG COCKTAILS TO INDUCE GLIOBLASTOMA.2) UCSF PRECLINICAL CORE FOR DRUG... | 2023 |
| AZ Corona Virus Relief Fund | Phoenix, AZ | $1,000,000 | DIRECT COSTS FOR 24/7 VACCINATION POD EFFORTS IN THE STATE OF ARIZONA. | 2021 |
| Neuro Trials Llc | Phoenix, AZ | $600,000 | RESTRICTED FUNDS FOR THE PURCHASE OF A LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY (LC-MS/MS) | 2021 |
| Neurotrials Llc | Phoenix, AZ | $494,429 | ADVERTISING #3. ADVERTISING AT SKY HARBOR AIRPORT. | 2021 |
| Neurotrials Llc | Phoenix, AZ | $450,000 | CEREBROSPINAL FLUID ANALYSIS WITH T-GEN. | 2022 |
| Society of St Vincent De Paul | Phoenix, AZ | $380,000 | CENTER FOR FAMILY WELLNESS ESTABLISHED TO FOCUS ON THE PREVENTION AND MANAGEMENT OF CHRONIC DISEASES THROUGH... | 2023 |
| Swedish Medical Center | Seattle, WA | $300,500 | ASSESS COMBINATIONS OF SMALL MOLECULES AND IMMUNOTHERAPIES FOR KILLING GLIOBLASTOMA TUMOR CELLS IN A PERSONALIZED EX... | 2023 |
| MAYO Clinic College of Medicine | Rochester, MN | $300,000 | IMMUNOSTIMULATORY BACTERIAL ANTIGENS EXPRESSED IN ONCOLYTIC VIRAL PLATFORMS WILL BE TESTED IN PRECLINICAL MODELS OF... | 2021 |
| Fred Hutchison Cancer Research Cent | Seattle, WA | $300,000 | (YEAR 2 OF 2) DR ERIC HOLLAND TRANSLATIONAL GLIOMA AWARD - CO CLINICAL TRIALS FOR GENE FUSION DRIVEN BRAIN TUMORS... | 2021 |
| University of Michigan | Ann Arbor, MI | $300,000 | NEW METHODS WILL BE DEVELOPED TO MEASURE THE ACTIVITY OF TUMOR METABOLIC PATHWAYS IN PATIENTS WITH GLIOBLASTOMA AND... | 2021 |
| UNIV of New Mexico Health Sciences | Albuquerque, NM | $300,000 | IDENTIFY MECHANISMS UNDERLYING INFLAMMATORY CELL CONTRIBUTION TO THE EMERGENCE OF THE RECURRENT TUMOR BY SINGLE-CELL... | 2021 |
| UNIV of Miami Miller School of MEDI | Miami, FL | $300,000 | USING PATIENT DERIVED ORTHOTOPIC XENOGRAFT MODELS AND A NOVEL IMMUNOCOMPETENT MODEL OF GBM, THE EFFICACY OF A... | 2021 |
| City of Hope Medical Center | Duarte, CA | $300,000 | ENHANCING CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY FOR GLIOBLASTOMA THROUGH THE INDUCTION OF IFN-SIGNALING... | 2021 |
| MAYO Clinic | Jacksonville, FL | $300,000 | DEVELOPMENT OF A TRANSCRIPTOMICALLY-GUIDED THERAPEUTIC STRATEGY THAT COMBINES TARGETED THERAPIES THAT BOTH... | 2021 |
| Yale Cancer Center | New Haven, CT | $300,000 | USE OF A NOVEL TRANSFORMATIONAL PLATFORM FOR RAPID IDENTIFICATION OF TARGETS AND TREATMENTS TO INHIBIT GROWTH AND... | 2021 |
| H Lee Moffitt Cancer Center | Rochester, MN | $300,000 | IN EXAMINING THE ROLE OF TUMORS CELLS IN MODULATING BONE MARROW-DERIVED MACROPHAGES AND MICROGLIA, THIS STUDY SEEKS... | 2021 |
| UC San Diego | La Jolla, CA | $300,000 | SMALL MOLECULE REGULATION OF REST PROTEIN LEVELS PROVIDES AN IDEAL PLATFORM FOR DEVELOPING A NEW THERAPEUTIC FOR THE... | 2023 |
| City of Hope Medical Center | Duarte, CA | $300,000 | PHASE I CLINICAL TRIAL TO EVALUATE THE FEASIBILITY, SAFETY, AND CLINICAL EFFICACY OF TGF-RESISTANT ILIRa2-CAR T... | 2023 |
| MAYO Clinic | Jacksonville, FL | $300,000 | IDENTIFY THE ONCOGENIC SIGNALING DEPENDENCIES THAT CHARACTERIZE EACH OF THE CELLULAR SUBPOPULATIONS THAT COMPRISE A... | 2023 |
| University of TX MD Anderson Cancer | Houston, TX | $300,000 | PROJECT SEEKS TO PRECLINICALLY OPTIMIZE NOVEL THERAPEUTIC APPROACHES FOR ATRX-DEFICIENT MALIGNANT GLIOMAS TARGETING... | 2023 |
Looking for more funders like Ben and Catherine Ivy Foundation? Open the free Texas funder database and search 178,000+ foundations by state, type, and giving size.
Want to compare open opportunities instead? Open the free Texas grant database for active grants from federal, state, foundation, and corporate funders.